Immunocore Holdings (IMCR) EBIAT (2023 - 2025)
Historic EBIAT for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to -$177000.0.
- Immunocore Holdings' EBIAT fell 10202.61% to -$177000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.2 million, marking a year-over-year increase of 3787.99%. This contributed to the annual value of -$51.1 million for FY2024, which is 759.67% up from last year.
- As of Q3 2025, Immunocore Holdings' EBIAT stood at -$177000.0, which was down 10202.61% from -$10.3 million recorded in Q2 2025.
- In the past 5 years, Immunocore Holdings' EBIAT ranged from a high of $8.7 million in Q3 2024 and a low of -$53.2 million during Q4 2021
- For the 5-year period, Immunocore Holdings' EBIAT averaged around -$18.0 million, with its median value being -$18.2 million (2023).
- As far as peak fluctuations go, Immunocore Holdings' EBIAT plummeted by 12859.06% in 2023, and later skyrocketed by 86423.84% in 2024.
- Immunocore Holdings' EBIAT (Quarter) stood at -$53.2 million in 2021, then surged by 34.73% to -$34.7 million in 2022, then soared by 43.15% to -$19.7 million in 2023, then decreased by 20.48% to -$23.8 million in 2024, then skyrocketed by 99.26% to -$177000.0 in 2025.
- Its EBIAT stands at -$177000.0 for Q3 2025, versus -$10.3 million for Q2 2025 and $5.0 million for Q1 2025.